News Conference News TCT 2017 Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used Todd Neale November 02, 2017
Presentation TCT 2017 When Bleeding Occurs on Warfarin or NOAC: Reversal Strategies Presenter: Robert A. Harrington, Kurt Huber, Michael D. Ezekowitz November 01, 2017
Presentation TCT 2017 Amulet: Data Synthesis and Ongoing Trials Presenter: William A. Gray, Vivek Y. Reddy, Fabian Nietlispach October 30, 2017
Presentation TCT 2017 WATCHMAN: Data Synthesis and Ongoing Trials Presenter: William A. Gray, Vivek Y. Reddy October 30, 2017
Presentation TCT 2017 Do the PIONEER and RE-DUAL Results Alter LAA Closure Decisions? Presenter: William A. Gray, Vivek Y. Reddy, C. Michael Gibson October 30, 2017
Presentation TCT 2017 Should the Improved Results With NOACs Compared to Warfarin Change LAA Closure Decisions? Presenter: William A. Gray, Vivek Y. Reddy, Kurt Huber October 30, 2017
Presentation TCT 2017 Atrial Fibrillation and PCI/ACS: NOACs, Dual Therapy, and Triple Therapy Presenter: Thomas H. Maloney, C. Michael Gibson October 30, 2017
Presentation TCT 2017 Strengths and Limitations of VKA and NOACs in Clinical Practice Presenter: Christopher B. Granger, Horst Sievert October 30, 2017